Krogh, DK
Anders Staermose Krogh, Kobenhavn O DK
Patent application number | Description | Published |
---|---|---|
20090239815 | Novel human microRNAs associated with cancer - The invention provides new sequences for human microRNAs associated with cancer which may be used as molecular markers for cancer diagnostics or as therapeutic targets or agents. | 09-24-2009 |
20120184603 | NOVEL HUMAN MICRORNAS ASSOCIATED WITH CANCER - The invention provides new sequences for human microRNAs associated with cancer which may be used as molecular markers for cancer diagnostics or as therapeutic targets or agents. | 07-19-2012 |
Berit O. Krogh, Roedovre DK
Patent application number | Description | Published |
---|---|---|
20160032012 | ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR - The application discloses a combination of two monospecific TFPI antibodies, wherein one antibody is capable of specifically binding TFPI (1-181) and the other antibody is capable of specifically binding TFPI (182-276), as well as bispecific anti-TFPI antibodies derived from two such monospecific antibodies. Both the combination of the two monospecific antibodies and the bispecific antibody strongly enhance thrombin generation by neutralising full length TFPIα, even where the concentration of TFPI is abnormally elevated. | 02-04-2016 |
Berit Olsen Krogh, Roedovre DK
Patent application number | Description | Published |
---|---|---|
20130251721 | Antibodies Against Tissue Factor Pathway Inhibitor - The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy. | 09-26-2013 |
20130251722 | Antibodies Against Tissue Factor Pathway Inhibitor - The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy. | 09-26-2013 |
20130323259 | IL-21 LIGANDS - The present invention relates to IL-21 ligands binding to a discontinuous epitope on the surface of the IL-21 molecule as well as use thereof. | 12-05-2013 |
20140170153 | IL-21 EPITOPE AND IL-21 LIGANDS - The present invention relates to IL-21 ligands, such as e.g. antibodies, as well as use thereof. | 06-19-2014 |
Berit Olsen Krogh, Rodovre DK
Patent application number | Description | Published |
---|---|---|
20110213125 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 09-01-2011 |
20110318356 | Antibodies Against Tissue Factor Pathway Inhibitor - The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy. | 12-29-2011 |
20120195888 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 08-02-2012 |
20130101602 | Humanized Antibodies Against Human Interferon-Alpha - The present invention provides humanized anti-human IFN-α monoclonal antibodies useful for therapeutic applications in humans. Preferred antibodies are humanized versions of murine antibodies ACO-1 and ACO-2, as well as variants thereof. | 04-25-2013 |
Kim Krogh, Copenhagen V DK
Patent application number | Description | Published |
---|---|---|
20140100038 | GAME SYSTEM FOR VARIOUS TYPE APPARATUS - The game system has at least one shared database which may be shared by various games. The database stores accumulated data for the first online game and the accumulated data may reflect game scenarios of the second online game. For example, the user of the first online game, which is an online game for personal computers, can play the second online game by means of mobile apparatus during commuting times. The result of the second online game may reflect the situations or conditions of the first online game. The players can feel playing their favourite game even when they cannot use their personal computers. | 04-10-2014 |
Kim Loekkegaard Krogh, Soenderborg DK
Patent application number | Description | Published |
---|---|---|
20100269687 | HYDRAULIC AXIAL PISTON MACHINE - The invention concerns a hydraulic axial piston machine with a housing, in which a cylinder drum having at least one cylinder is arranged to be rotatable around an axis, in which cylinder is located a piston that is supported on a swashplate, whose inclination angle is adjustable in an adjustment plane. It is endeavoured to keep the cost of manufacturing individual parts of the axial piston machine small. For this purpose it is provided that on the side facing away from the cylinder drum ( | 10-28-2010 |
Kristian Krogh, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20080201805 | Polypeptides Having Beta-Glucosidase Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 08-21-2008 |
20110061135 | Polypeptides having endoglucanase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 03-10-2011 |
20110131686 | Polypeptides having beta-glucosidase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 06-02-2011 |
20120088274 | Polypeptides having Beta-Glucosidase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 04-12-2012 |
20120258520 | Polypeptides having Beta-Glucosidase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 10-11-2012 |
20130340122 | Polypeptides having endoglucanase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 12-19-2013 |
20140096287 | Polypeptides having endoglucanase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 04-03-2014 |
20150110765 | Polypeptides Having Alpha-Glucuronidase Activity And Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having alpha-glucuronidase activity, catalytic domains and polynucleotides encoding the polypeptides, catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides or catalytic domains. | 04-23-2015 |
20150152456 | Polypeptides Having Glucuronyl Esterase Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having glucuronyl esterase activity, catalytic domains and polynucleotides encoding the polypeptides or catalytic domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides or catalytic domains. | 06-04-2015 |
Kristian Bertel Roemer Moerkeberg Krogh, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20110053213 | Polypeptides Having Ferulic Acid Esterase Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having ferulic acid esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 03-03-2011 |
Kristian Bertel Romer Morkeberg Krogh, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20120151633 | Polypeptides having endoglucanase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 06-14-2012 |
20120331587 | Polypeptides having endoglucanase activity and polynucleotides encoding same - The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. | 12-27-2012 |
Kristian B. R. M. Krogh, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20150291947 | CELLOBIOHYDROLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME - The present invention relates to cellobiohydrolase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants. | 10-15-2015 |
Lars Krogh, Ega DK
Patent application number | Description | Published |
---|---|---|
20110198965 | SLIP RING ASSEMBLY WITH COOLING - The present invention relates to a slip ring assembly for providing electricity to or from a rotor rotating in relation to a stator in a generator or an electrical motor. The slip ring unit rotates around a centre axis and has at least one first slip ring with an outer surface, a diameter, and a width. Also, the assembly comprises at least one conductive means, such as a brush, having conductive contact with the surface of the slip ring, and a housing in which the slip ring unit and the conductive means are situated. Furthermore, the assembly has a suction means in connection with the housing for suction of gas from within the housing out through a suction outlet in the housing. In addition, the housing has a suction inlet which is connected with a guiding means. The guiding means has an aperture facing the slip ring surface, and the aperture is positioned at a predetermined distance from the surface of the slip ring so that the gas is able to cool the surface of the slip ring. Also, the invention relates to a generator and a wind turbine having such a slip ring assembly. | 08-18-2011 |
20110210644 | SLIP RING ASSEMBLY WITH SHAFT HOLDER - The present invention relates to a slip ring assembly | 09-01-2011 |
Mikael Krogh, Skodstrup DK
Patent application number | Description | Published |
---|---|---|
20090075579 | CUTTING APPARATUS - An apparatus for cutting of material such as a piece of meat from e.g. an animal, poultry, fish etc., said apparatus ( | 03-19-2009 |
20100249992 | METHOD AND A SYSTEM FOR BATCHING OF OBJECTS - Method and system for batching of supplied objects in batches in such a manner that a batch fulfils predefined criteria as regards the number of objects, weight, orientation and/or type(s) of objects, wherein | 09-30-2010 |
Mikkel Verner Krogh, Brande DK
Patent application number | Description | Published |
---|---|---|
20100225120 | METHOD AND ARRANGEMENT TO INSTALL A WIND-TURBINE - At least one blade of the wind-turbine is attached firm but detachable with the tower by a fixture. The tower and the attached blade are transported to a planned site. The tower and the attached blade are brought together into an upright position in a single lift-action. A hub and a nacelle of the wind-turbine are mounted on the top of the tower. A wire of a winch, which is located inside the nacelle or the hub, is connected with a root of the blade. The blade is detached from the tower by unlocking the fixture. The blade is lift up to the hub for its attachment there. | 09-09-2010 |
20110031292 | Tip end bracket - A mounting bracket device and method for mounting a blade of a wind turbine to a transportation device are disclosed. The mounting bracket device includes a clamping device for holding the blade, an adjustment system, and a connecting system adapted for being removably connected to the transportation device. The connecting system removably connects the clamping device and the adjustment system to the transportation device. The adjustment system is adapted to align the clamping device with respect to the transportation device around the first rotary axis and around a second rotary axis. | 02-10-2011 |
20110318159 | Arrangement for Lifting a Tower Wall Portion of a Wind Turbine and Method for Lifting a Tower Wall Portion of a Wind Turbine - An arrangement for lifting a tower wall portion of a wind turbine is provided. The arrangement includes a bar, a first holding member and a second holding member. The bar is connectable to a coupling element of a lift. The first and second holding members have respective first and second engagement portions adapted for engaging the tower wall portion at a first position and a second position respectively, the first position being different from the second position. The first and second holding members are releasably lockable at the bar such that the first engagement portion and the second engagement portion are a first distance away from each other. The first and second holding members are also releasably lockable at the bar such that the first engagement portion and the second engagement portion are a second distance away from each other, the second distance being different from the first distance. | 12-29-2011 |
20120107084 | LIFTING FITTING - A lifting fitting for lifting a series of elements of different sizes in a wind turbine is proposed. The lifting fitting has a base plate having at least one central slotted hole shaped to accommodate a fastener for fastening the lifting fitting to an element to be lifted, at least two outer slotted holes each shaped to accommodate a further fastener for fastening the lifting fitting to an element to be lifted. The outer slotted holes are arranged transverse to the central slotted hole. The lifting fitting is connected to a lifting apparatus for lifting the element. A method of assembling the series of elements is proposed. The elements are successively lifted into place. The lifting fitting can be used in the assembly of a wind turbine tower having individually liftable tower sections for lifting the tower sections into place. | 05-03-2012 |
20120192420 | Lifting system and method for lifting rotor blades of wind turbines - A lifting system for lifting rotor blades of wind turbines includes a plurality of frame structures each being configured to support a rotor blade. Additionally, the lifting system includes a lifting structure which is attachable to a lifting device, and a number of lifting connectors configured to connect a pack of frame structures to the lifting structure. Furthermore, a method for lifting rotor blades of wind turbines by using a lifting device and a method for installation of rotor blades of wind turbines are provided. | 08-02-2012 |
Nicolas Otto Krogh, Virum DK
Patent application number | Description | Published |
---|---|---|
20090104277 | Preparation of Molecular Imprinted Polymers - One aspect is a method for improved preparation of molecular imprinted polymer (MIP) particles, where initial compositions comprising insoluble MIP particles are enriched for those MIP particles that bind a particular target molecule, thus excluding non-binding and weakly binding particles from the final composition. Enrichment is typically accomplished via use of chromatographic methods capable of separating particulate material or by means of agglutination. Another aspect is preparation of improved insoluble MIPs by use of extended micronization of raw MIP particles with a view to expose a large number of binding sites per mass unit of MIP particles. In preferred embodiments the two aspects are combined. The resulting improved MIPs may be used for diagnostic, analytical and therapeutic purposes, notably as orally administered drugs which can bind substances such as cholesterol and bile acids and bile acid salts in the gastrointestinal tract. | 04-23-2009 |
20120171154 | PURIFICATION OF MULTI-SPECIFIC RECEPTORS - Disclosed is a method for preparing a composition enriched for receptors (typically molecular impringet polymers, MIPs) that bind an agent, where said receptors each specifically bind at least two discrete sites on said agent, by subjecting a sample of receptors to a first step of affinity purification with the agent where one binding site on the agent is non-accessible for binding to the receptors and subsequently subjecting the purified receptors to at least one further step of affinity purification with the agent where a second binding site on the agent is non-accessible. Also disclosed is a method for treatment, amelioration or prophylaxis of a disease selected from the group consisting of phenylketonuria (PKU, Følling's disease), hyperphenylalaninemia (HPA), alcaptonuria (black urine disease), tyrosinemia, hypertyrosinemia, myasthenia gravis, histidinemia, urocanic aciduria, maple syrup urine disease (MSUD), isovaleric acidemia (isovaleryl-CoA dehydrogenase deficiency), homocystinuria, propionic acidemia, methylmalonic acidemia, and glutaric aciduria Type 1 (GA-I), galactosemia, comprising administering to the gastrointestinal tract of a patient in need thereof an effective amount of a composition of molecular imprinted polymers (MIPs), said composition being capable of binding a symptom provoking agent of said disease. | 07-05-2012 |
20150031779 | PREPARATION OF MOLECULAR IMPRINTED POLYMERS BY CROSS-LINKING - Provided is an improved method for preparation of insoluble molecular imprinted polymers (MIPs), the method comprising: a) providing soluble or semi-soluble MIPs that 1) substantially all bind template agents and 2) have sizes which enable their separation in a chromatographic step utilizing packed bed chromatography, b) cross-linking the template agent binding soluble MIPs provided in step a so as to obtain insoluble template agent binding MIPs, and c) optionally isolating, concentrating or purifying the MIPs obtained by the cross-linking in step b. In an interesting embodiment, step a includes an affinity purification procedure, which ensures that the MIPs provided in step a are indeed all binders of the template. | 01-29-2015 |
20150374742 | PURIFICATION OF MULTI-SPECIFIC RECEPTORS - Disclosed is a method for preparing a composition enriched for receptors (typically molecular impringet polymers, MIPs) that bind an agent, where said receptors each specifically bind at least two discrete sites on said agent, by subjecting a sample of receptors to a first step of affinity purification with the agent where one binding site on the agent is non-accessible for binding to the receptors and subsequently subjecting the purified receptors to at least one further step of affinity purification with the agent where a second binding site on the agent is non-accessible. | 12-31-2015 |
Peter Gall Krogh, Hojbjerg DK
Patent application number | Description | Published |
---|---|---|
20100121919 | System and a method for sharing information interactively among two or more users - An assembly of a plurality of media providers, each media provider having set a media exchange level. Each media exchange level comprising or encompassing one or more types of media to be exchanged. The media providers outputting to the other media providers the set levels, and if two media providers have levels set which have at least one type of media to be exchanged in common, the exchange of such media is started automatically. Media types to exchange may be photos, podcasts, music, voice, videos & movies, streamed TV/video/audio, such as airborne transmissions, graphics & text, e-mails, running application programs, such as an active web browser window, or the like | 05-13-2010 |
Poul Hassan Agha Krogh, Fredericia DK
Patent application number | Description | Published |
---|---|---|
20090204702 | SYSTEM AND METHOD FOR NETWORK MANAGEMENT USING SELF-DISCOVERING THIN AGENTS - In one embodiment, a computer-implemented method of managing a computer network includes installing an agent in each of a plurality of network nodes in the network. The agent may be configured to identify one or more types of network resources attached to a particular node with which the agent is associated. One or more roles may be assigned to or by the agent based, at least in part, upon the one or more types of network resources identified by the agent. Functions associated with the identified roles may be executed. Monitoring the status of each agent may also be carried out. In another embodiment, a network management system includes an agent executing within an associated network node of the network. The agent may be configured to operate so as to identify one or more types of resources attached to the network node. The agent may be assigned one or more roles based, at least in part, on an inference based upon the one or more types of attached resources identified by the agent. | 08-13-2009 |
Rasmus Linnemann Krogh, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20090258377 | Method of Measuring Enzymatic Activity of Adsorbed Allergenic Enzyme - The invention relates to a method of measuring the immunological activity of a vaccine preparation in the form of a mixture of one or more allergenic enzyme(s) and an oxygen-containing metal salt adjuvant, wherein the mixture comprises a liquid phase and a solid phase, and wherein at least a part of the allergenic enzyme(s) is adsorbed to the solid phase, the method comprising the steps of measuring the enzymatic activity of the mixture in an enzyme activity assay, and using the measurement obtained as an indication of the immunological activity of the vaccine preparation, or using the measurement obtained for quantifying the amount of allergenic enzyme. | 10-15-2009 |
Søren Christian Krogh, Stenlose DK
Patent application number | Description | Published |
---|---|---|
20100015691 | Apparatus for Hemolyzing a Blood Sample and for Measuring at Least One Parameter Thereof - An apparatus for hemolyzing a blood sample and for measuring at least one parameter thereof comprises a sample chamber for accommodation of the blood sample, the sample chamber having a first sidewall and an opposite second sidewall. The apparatus also comprises ultrasonic generator for generating ultrasonic waves in the first and second sidewalls so as to cause the blood sample provided between the first and second sidewall to be hemolyzed. Further, the apparatus comprises an optical measuring device for measuring the at least one parameter in the hemolyzed blood sample when the hemolyzed blood sample is provided between the first and second sidewalls. The ultrasonic generator of the apparatus comprises a first ultrasonic generator for generating ultrasonic waves in the first sidewall and a second ultrasonic generator for generating ultrasonic waves in the second sidewall. | 01-21-2010 |
Soren Friis Krogh, Solrod Strand DK
Patent application number | Description | Published |
---|---|---|
20100008180 | APPARATUS FOR DISSOLVING SOLID PARTICLES AND LIQUID SUBSTANCES IN A LIQUID - The invention relates to an apparatus for admixture and/or dissolution of solid particles and/or liquid substances in a liquid, said apparatus being connected to a field sprayer or the like and comprising a container part with lid, supply of water and discharge pipe for the admixture or the solution, wherein an outlet opening ( | 01-14-2010 |
Thomas N. Krogh, Jyllinge DK
Patent application number | Description | Published |
---|---|---|
20150368313 | Novel Glucagon Analogues - The present invention relates to novel glucagon peptides with improved stability and solubility at neutral pH, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The glucagon peptides of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity. | 12-24-2015 |
Thomas Nylandsted Krogh, Jyllinge DK
Patent application number | Description | Published |
---|---|---|
20140031278 | Novel Glucagon Analogues - The present invention relates to novel glucagon peptides with improved stability and solubility at neutral pH, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The glucagon peptides of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity. | 01-30-2014 |